Relation between Blood Pressure Management and Renal Effects of Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Patients with Chronic Kidney Disease.
Kazuo KobayashiMasao ToyodaNoriko KaneyamaNobuo HatoriTakayuki FurukiHiroyuki SakaiMasahiro TakihataTomoya UmezonoShun ItoDaisuke SuzukiHiroshi TakedaAkira KanamoriHisakazu DegawaHareaki YamamotoHideo MachimuraAtsuko MokuboKeiichi ChinMitsuo ObanaToshimasa HishikiKouta AoyamaShinichi NakajimaShinichi UmezawaHidetoshi ShimuraTogo AoyamaMasaaki MiyakawaPublished in: Journal of diabetes research (2019)
Our results confirmed that blood pressure management status after treatment with SGLT2 inhibitors influences the extent of change in urinary albumin-creatinine ratio. Stricter blood pressure management is needed to allow the renoprotective effects of sodium-glucose cotransporter 2 inhibitors.